Preventing Recurrent UTI With Vaginal Estrogen

Completed · Phase 4

Conditions studied: Recurrent Urinary Tract Infection, Urinary Tract Infections, Cystitis Recurrent

In brief

Among postmenopausal women who suffer from recurrent urinary tract infections (UTI), vaginal estrogen therapy prevents UTI recurrences for 50% of sufferers. This research will investigate why some women benefit but others do not, focusing on (a) the effects of vaginal estrogen therapy on the bacteria that inhabit the vagina and bladder, (b) its influence on immune responses in both compartments, and (c) the extent to which those changes are critical to successful UTI prevention. The findings will be a first step in the development of more effective strategies to prevent UTI, one of the most common and costly benign urologic conditions.

Key facts

Study ID
NCT05551949
Run by
Johns Hopkins University
People needed
27
Starts
2022-01-01
Expected to finish
2025-08-31
Last updated by the study team
2026-03-05

Who can join

Age: 55 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.